Acquired Resistance to HER2-Targeted Therapies Creates Vulnerability to ATP Synthase Inhibition.
Animals
Antineoplastic Combined Chemotherapy Protocols
/ pharmacology
Apoptosis
Breast Neoplasms
/ drug therapy
Cell Proliferation
Drug Resistance, Neoplasm
/ drug effects
Enzyme Inhibitors
/ pharmacology
Female
Humans
Mice
Mice, Inbred NOD
Mice, SCID
Mitochondrial Proton-Translocating ATPases
/ antagonists & inhibitors
Oligomycins
/ administration & dosage
Receptor, ErbB-2
/ antagonists & inhibitors
Trastuzumab
/ administration & dosage
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
01 02 2020
01 02 2020
Historique:
received:
19
12
2018
revised:
28
05
2019
accepted:
30
10
2019
pubmed:
7
11
2019
medline:
18
8
2020
entrez:
7
11
2019
Statut:
ppublish
Résumé
Acquired resistance to HER2-targeted therapies occurs frequently in HER2
Identifiants
pubmed: 31690671
pii: 0008-5472.CAN-18-3985
doi: 10.1158/0008-5472.CAN-18-3985
pmc: PMC7002225
mid: NIHMS1541926
doi:
Substances chimiques
ATP5F1B protein, human
0
Enzyme Inhibitors
0
Oligomycins
0
oligomycin A
05HQS4AI99
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Mitochondrial Proton-Translocating ATPases
EC 3.6.3.-
Trastuzumab
P188ANX8CK
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
524-535Subventions
Organisme : NCI NIH HHS
ID : R21 CA187862
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIA NIH HHS
ID : F32 AG052995
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216101
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016359
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014195
Pays : United States
Informations de copyright
©2019 American Association for Cancer Research.
Références
Science. 1987 Jan 9;235(4785):177-82
pubmed: 3798106
PLoS Biol. 2018 Aug 6;16(8):e2006134
pubmed: 30080846
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Genet. 2014 Apr;46(4):364-70
pubmed: 24584072
Cancer Cell. 2004 Apr;5(4):317-28
pubmed: 15093539
Cancer Cell. 2014 Mar 17;25(3):282-303
pubmed: 24651011
Cell Cycle. 2008 Apr 15;7(8):1054-66
pubmed: 18414044
BMC Cancer. 2014 Jul 15;14:515
pubmed: 25026897
Toxicol In Vitro. 2007 Aug;21(5):902-11
pubmed: 17346924
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):1-6
pubmed: 28065746
N Engl J Med. 2015 Feb 19;372(8):724-34
pubmed: 25693012
Cancer Res. 2011 Mar 1;71(5):1871-82
pubmed: 21324925
Cancer Cell. 2015 Oct 12;28(4):472-485
pubmed: 26461093
Br J Cancer. 2006 Jan 30;94(2):259-67
pubmed: 16404427
Nature. 2014 Oct 30;514(7524):628-32
pubmed: 25119024
Clin Cancer Res. 2015 Mar 15;21(6):1360-72
pubmed: 25547679
Cancer Res. 2001 Jun 15;61(12):4892-900
pubmed: 11406568
Nat Med. 2000 Apr;6(4):443-6
pubmed: 10742152
Cancer Res. 2017 Nov 1;77(21):e108-e110
pubmed: 29092952
Cancer Cell. 2013 Jun 10;23(6):811-25
pubmed: 23764003
Aging (Albany NY). 2016 Aug;8(8):1593-607
pubmed: 27344270
Cell. 2010 Apr 2;141(1):69-80
pubmed: 20371346
J Clin Oncol. 2014 Nov 20;32(33):3744-52
pubmed: 25332249
Cancer Res. 2000 Jul 1;60(13):3384-8
pubmed: 10910043
Cancer Res. 2001 Jun 15;61(12):4744-9
pubmed: 11406546
Cancer Cell. 2009 May 5;15(5):429-40
pubmed: 19411071
Nature. 2017 Nov 9;551(7679):247-250
pubmed: 29088702
Clin Cancer Res. 2018 Mar 1;24(5):1216-1226
pubmed: 29180608
J Clin Oncol. 2002 Feb 1;20(3):719-26
pubmed: 11821453
Cancer Cell. 2002 Aug;2(2):127-37
pubmed: 12204533
N Engl J Med. 2017 Jul 13;377(2):122-131
pubmed: 28581356
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Med. 2011 Apr;17(4):461-9
pubmed: 21399647
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Mol Cell. 2007 Oct 12;28(1):15-27
pubmed: 17936701
Biochim Biophys Acta. 2011 Jun;1807(6):543-51
pubmed: 21035425
Cell Stem Cell. 2017 Feb 2;20(2):233-246.e7
pubmed: 27989769
PLoS One. 2012;7(5):e37699
pubmed: 22629444
N Engl J Med. 2005 Oct 20;353(16):1659-72
pubmed: 16236737
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
Cancer Cell. 2004 Aug;6(2):117-27
pubmed: 15324695
Clin Med Insights Oncol. 2016 Mar 28;10(Suppl 1):21-30
pubmed: 27042153
J Natl Cancer Inst. 2015 May 19;107(8):null
pubmed: 25991002
Oncotarget. 2016 Jun 28;7(26):39931-39944
pubmed: 27224921
Biochim Biophys Acta. 2014 Dec;1846(2):353-65
pubmed: 25065528
N Engl J Med. 2005 Oct 20;353(16):1673-84
pubmed: 16236738
N Engl J Med. 2011 Oct 6;365(14):1273-83
pubmed: 21991949
Cancer Res. 2011 Jul 1;71(13):4585-97
pubmed: 21498634